PMDA — authorised 24 February 2021
- Marketing authorisation holder: Fujimoto Pharmaceutical Corporation
- Status: approved
🇯🇵 Thalomid in Japan
PMDA authorised Thalomid on 24 February 2021
Marketing authorisation
Thalomid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Thalomid approved in Japan?
Yes. PMDA authorised it on 24 February 2021.
Who is the marketing authorisation holder for Thalomid in Japan?
Fujimoto Pharmaceutical Corporation holds the Japanese marketing authorisation.